BIRC5 and colorectal cancer: Here we describe the use of an oligonucleotide chimera made up of an EpCAM-specific aptamer and a survivin siRNA to downregulate survivin in both the bulk and colorectal cancer stem cells without the aid of transfection agent or other delivery vehicles such as viral vectors or nanodrug carriers.